TCTMD In total, 1,829 STEMI patients undergoing primary PCI were randomized without consent to receive either unfractionated heparin or bivalirudin prior to the procedure. Bivalirudin was associated with higher rates of MACE and stent thrombosis compared ... and more »
Medscape In addition, there are downsides to prophylaxis, including "patient discomfort from injections, cost, nursing time, and the possibility of drug reactions, including heparin -induced thrombocytopenia," said Dr. Grant. "We are one of the first groups to ...
Medscape Dr. Richardson's conviction in the product as a novel therapy for VOD was borne out of the frustration of seeing the adverse effects of the clot-busting therapies — heparin and tissue plasminogen activator (tPA) — used at the time. The first and very ...
Reuters UK The quality of China's supply chain made headlines in 2008 after dozens of people were killed or injured after taking Chinese suppliers of the blood-thinner ...
Healio WASHINGTON — Bivalirudin was associated with reduced mortality and major bleeding compared with heparin with or without a glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI, according to results of a pooled analysis of the ...
Science Codex WASHINGTON (March 31, 2014) — In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular eve...
Healio April 2, 2014. WASHINGTON — Results from a single-center study of patients with STEMI undergoing primary PCI showed that heparin was associated with reduced rates of MACE and stent thrombosis compared with bivalirudin at 28 days. Rod Stables, MD ...
Medscape The single-center randomized trial of unfractionated heparin vs bivalirudin (Angiomax, the Medicines Company) (with bailout GPIIb/IIIa inhibitors) in STEMI patients surprised attendees on the last day of the meeting by showing a significantly lower ...
